news

REUTERS: Biogen Bets Scientist Has Right Formula for Growth

REUTERS: Biogen Bets Scientist Has Right Formula for Growth

  • News
  • November 8, 2010

By Toni Clarke BOSTON (Reuters) - In picking George Scangos of Exelixis Inc (EXEL.O: Quote, Profile, Research, Stock Buzz) as its new chief executive, Biogen Idec Inc (BIIB.O: Quote, Profile, Research, Stock Buzz) is betting that scientific knowledge will trump commercial experience in helping to strengthen its portfolio of e... Read More

DBR VIEWPOINT: QE2…Road to Hell…the Sequel

DBR VIEWPOINT: QE2…Road to Hell…the Sequel

  • News
  • November 3, 2010

By Anders J. Maxwell U.S. equity and bond markets have now retraced their steps and are fully recovered from the precipitous fall of 2008. The financial markets’ rebound is in stark contrast to the “real economy.” September’s headline-grabbing jobless rate remains at 9.6%, with the Commerce Department estimating that one in f... Read More

WWD: Fashion’s M&A Game Heats Up

WWD: Fashion’s M&A Game Heats Up

  • News
  • September 30, 2010

by Evan Clark Forget the runway — the big changes in fashion this fall might come from the boardroom. An unusual combination of economic forces is coming together, pushing buyers and sellers closer together even as the economy skids along and consumers suffer through nearly 10 percent unemployment. Private equity... Read More

WSJ: A&P Mulls Selling Food Emporium Chain

WSJ: A&P Mulls Selling Food Emporium Chain

  • News
  • September 2, 2010

by Anjali Cordeiro and Paul Ziobro Great Atlantic & Pacific Tea Co., operator of the struggling A&P supermarket chain, is considering selling its Food Emporium stores as part of a boarder effort to rid itself of some assets and boost its liquidity, according to people familiar with the matter. The supermarket operator has... Read More

THE DEAL: Regis Explores Options

THE DEAL: Regis Explores Options

  • News
  • August 5, 2010

by Demitri Diakantonis Regis Corp. is looking to trim a few layers of debt. The operator of the Supercuts chain announced late Wednesday that it had hired Peter J. Solomon Co. to explore strategic alternatives. "During the past year, the board and management team have taken numerous concrete steps, including reducing overhead exp... Read More

DAILY BANKRUPTCY REVIEW: Beware Zombie Credit Markets

DAILY BANKRUPTCY REVIEW: Beware Zombie Credit Markets

  • News
  • July 12, 2010

By Anders J. Maxwell The movie “28 Days Later” is a chilling portrayal of a future where an uncontrolled virus turns society into a wilderness populated by zombies. Now, nearly 28 months since the onset of 2008's “great recession,” this science fiction thriller seems an apt metaphor for U.S. capital markets. Equity market gyrations have dra... Read More

Sanofi-aventis to Acquire TarGen Inc

Sanofi-aventis to Acquire TarGen Inc

  • News
  • June 30, 2010

San Diego, CA – June 30, 2010- TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis (EURONEXT: SAN and NYSE: SNY). Under the agreement, the ultimate purchase price will depend on the a... Read More